UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling

Annals of oncology, 2007-08, Vol.18 (8), p.1323-1328

2007

Volltextzugriff (PDF)

Abstract P1-09-09: Efficacy of estrogen receptor β agonists in the prevention of breast cancer progression to therapy resistance

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-09-09

2018

Volltextzugriff (PDF)

Abstract P1-04-01: Estrogen receptor β agonists inhibits syngeneic mammary tumor growth through cell-cycle arrest by modulating cell-cycle regulators

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-04-01

2019

Volltextzugriff (PDF)

Abstract P4-15-02: Investigating the use estrogen receptor β agonists in the prevention of breast cancer using a transgenic mouse model

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-15-02

2017

Volltextzugriff (PDF)

Abstract P6-11-15: Pre-clinical investigation of estrogen receptor β agonists for the treatment of breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P6-P6-11-15

2017

Volltextzugriff (PDF)

Abstract P3-04-03: Investigating the therapeutic use of estrogen receptor β agonists in breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-04-03

2016

Volltextzugriff (PDF)

Abstract P4-07-01: A small molecule inhibitor (ERX-41) induces endoplasmic reticulum stress in triple negative breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-07-01

2019

Volltextzugriff (PDF)

Abstract P1-09-06: Blocking ER coregulator signaling enhances CDK4/6 inhibitor palbociclib therapy in ER-positive advanced breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P1-P1-09-06

2018

Volltextzugriff (PDF)

Abstract P5-04-23: Enhancing the activity of a novel estrogen receptor coregulator binding modulator (ERX-11) against ER-positive therapy resistant breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-04-23

2019

Volltextzugriff (PDF)

Opium Alkaloid Noscapine is an Antitumor Agent that Arrests Metaphase and Induces Apoptosis in Dividing Cells

Proceedings of the National Academy of Sciences - PNAS, 1998-02, Vol.95 (4), p.1601-1606

1998

Volltextzugriff (PDF)

Abstract P2-06-02: Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P2-P2-06-02

2019

Volltextzugriff (PDF)

Abstract P5-09-14: Plant-derived estrogen receptorb agonists alone or in combination with aromatase inhibitors restore sensitivity in endocrine therapy resistant breast tumors

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P5-P5-09-14

2013

Volltextzugriff (PDF)

Abstract P2-05-01: Induction of PELP1 expression in mammary gland promotes tumorigenesis by enhancing CDK-CyclinD1 signaling

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-05-01

2013

Volltextzugriff (PDF)

Induction of aromatase expression in cervical carcinomas : Effects of endogenous estrogen on cervical cancer cell proliferation

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (23), p.11164-11173

2005

Volltextzugriff (PDF)

Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription

Fertility and sterility, 2008-10, Vol.90 (4), p.1487-1495

2008

Volltextzugriff (PDF)

Abstract P5-05-08: Obesity suppresses estrogen receptor beta expression in breast cancer cells via a HER2-mediated pathway

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P5-P5-05-08

2013

Volltextzugriff (PDF)

Abstract P1-06-01: NSAID use attenuates breast cancer recurrence in obese women: Role of prostaglandin-aromatase interactions

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P1-P1-06-01

2013

Volltextzugriff (PDF)

Abstract S3-04: ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.S3-S3-04

2016

Volltextzugriff (PDF)

P1-05-01: PELP1 Oncogenic Functions Involve Regulation of Histone Arginine Methylation

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-05-01

2011

Volltextzugriff (PDF)

P2-01-07: Proto-Oncogene PELP1 Promotes Metastasis through miR-200 Dependent Pathway

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P2-P2-01-07

2011

Volltextzugriff (PDF)

Abstract P6-04-07: Significance and therapeutic potential of PELP1-mTOR axis in breast cancer progression and therapy resistance

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P6-P6-04-07

2012

Volltextzugriff (PDF)

Abstract P5-04-04: Significance of PELP1/HDAC2/microRNA-200 regulatory network in EMT and metastasis of breast cancer

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.P5-P5-04-04

2012

Volltextzugriff (PDF)

P4-02-01: Bis(2-Ethylhexyl) Phthalate: A Potential Endocrine Disruptor Confer Letrozole Insensitivity and Induction of Aromatase Activity in Breast Cancer Cells

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-02-01

2011

Volltextzugriff (PDF)

P4-03-05: Development of an Inducible Estrogen Receptor Co-Activator PELP1 Mammary Tumor Model

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-03-05

2011

Volltextzugriff (PDF)

P4-02-08: Obesity-Induced Aromatase Expression in the Breast Microenvironment Promotes Estrogen Receptor Activity Independent of Circulating Estradiol Levels

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P4-P4-02-08

2011

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(61)
Buchkapitel
(1)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Female
(23)
Biological And Medical Sciences
(22)
Animals
(20)
Mice
(18)
Medical Sciences
(15)
Humans
(13)
Oncology
(13)
Tumors
(13)
Mice, Transgenic
(12)
Aromatase
(11)
Aromatase - Genetics
(11)
Gynecology. Andrology. Obstetrics
(8)
Obstetrics & Gynecology
(8)
Aromatase - Metabolism
(7)
Endocrinology & Metabolism
(7)
Gene Expression
(7)
Mammary Neoplasms, Experimental - Enzymology
(7)
Aromatase Inhibitors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling

Abstract P1-09-09: Efficacy of estrogen receptor β agonists in the prevention of breast cancer progression to therapy resistance

Abstract P1-04-01: Estrogen receptor β agonists inhibits syngeneic mammary tumor growth through cell-cycle arrest by modulating cell-cycle regulators

Abstract P4-15-02: Investigating the use estrogen receptor β agonists in the prevention of breast cancer using a transgenic mouse model

Abstract P6-11-15: Pre-clinical investigation of estrogen receptor β agonists for the treatment of breast cancer

Abstract P3-04-03: Investigating the therapeutic use of estrogen receptor β agonists in breast cancer

Abstract P4-07-01: A small molecule inhibitor (ERX-41) induces endoplasmic reticulum stress in triple negative breast cancer

Abstract P1-09-06: Blocking ER coregulator signaling enhances CDK4/6 inhibitor palbociclib therapy in ER-positive advanced breast cancer

Abstract P5-04-23: Enhancing the activity of a novel estrogen receptor coregulator binding modulator (ERX-11) against ER-positive therapy resistant breast cancer

Opium Alkaloid Noscapine is an Antitumor Agent that Arrests Metaphase and Induces Apoptosis in Dividing Cells

Abstract P2-06-02: Development of a first-in-class small molecule inhibitor (EC359) targeting oncogenic LIF/LIFR signaling for the treatment of triple negative breast cancer

Abstract P5-09-14: Plant-derived estrogen receptorb agonists alone or in combination with aromatase inhibitors restore sensitivity in endocrine therapy resistant breast tumors

Abstract P2-05-01: Induction of PELP1 expression in mammary gland promotes tumorigenesis by enhancing CDK-CyclinD1 signaling

Induction of aromatase expression in cervical carcinomas : Effects of endogenous estrogen on cervical cancer cell proliferation

Modeling the early endometriotic lesion: mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription

Abstract P5-05-08: Obesity suppresses estrogen receptor beta expression in breast cancer cells via a HER2-mediated pathway

Abstract P1-06-01: NSAID use attenuates breast cancer recurrence in obese women: Role of prostaglandin-aromatase interactions

Abstract S3-04: ESR1 coregulator binding inhibitor (ECBI) as a novel therapeutic to target hormone therapy resistant metastatic breast cancer

P1-05-01: PELP1 Oncogenic Functions Involve Regulation of Histone Arginine Methylation

P2-01-07: Proto-Oncogene PELP1 Promotes Metastasis through miR-200 Dependent Pathway

Abstract P6-04-07: Significance and therapeutic potential of PELP1-mTOR axis in breast cancer progression and therapy resistance

Abstract P5-04-04: Significance of PELP1/HDAC2/microRNA-200 regulatory network in EMT and metastasis of breast cancer

P4-02-01: Bis(2-Ethylhexyl) Phthalate: A Potential Endocrine Disruptor Confer Letrozole Insensitivity and Induction of Aromatase Activity in Breast Cancer Cells

P4-03-05: Development of an Inducible Estrogen Receptor Co-Activator PELP1 Mammary Tumor Model

P4-02-08: Obesity-Induced Aromatase Expression in the Breast Microenvironment Promotes Estrogen Receptor Activity Independent of Circulating Estradiol Levels

Suchergebnisse filtern